KRAS and neoplasm: As shown in Table 1, a statistically significant difference was observed in lymph node enlargement between KRAS wild‐type and mutant groups in the training set (p = 0.009), and in the test set, a significant difference was found in maximum tumor diameter between the two groups (p = 0.039).